About Us
A global medical technology company, BrainsWay focuses on developing cutting edge medical devices that help advance the level of treatment offered to patients. To do so, BrainsWay’s advanced flagship technology of Deep Transcranial Magnetic Stimulation (Deep TMS) is expanding the treatment of mental health beyond what was thought possible.
BrainsWay’s non-invasive Deep TMS treatment has been proven to offer significant results, by directly stimulating deeper and broader areas of the brain, effectively treating conditions such as depression and OCD.
With numerous studies and a growing number of patients and healthcare providers attesting to its success, BrainsWay’s cutting edge technology is changing the field of mental health.
Treatments
BrainsWay’s innovative treatment has been proven beneficial in treating a number of mental health conditions, thanks to its safety and efficacy.
Featured Treatments
Major Depressive Disorder (MDD) treatment
BrainsWay’s safe and effective Deep TMS is FDA-cleared to treat major depressive disorder, offering patients a better quality of life.
Obsessive Compulsive Disorder (OCD) treatment
BrainsWay introduces the first FDA-cleared (de novo) non-invasive medical device for the treatment of OCD.
Our Treatments
Individuals looking for a therapy that works, and particularly treatment-resistant patients, can finally find relief thanks to Deep TMS’s effective treatment:
Patients & Healthcare Providers
BrainsWay has revolutionized the treatment of depression and OCD. With BrainsWay’s unique therapy, you can regain a sense of well-being and enjoy a better quality of life in just a few weeks.
Patients & Healthcare Providers
BrainsWay seeks to ensure that mental health providers, referral partners, and patients have the support necessary to achieve their goals.
From numerous studies to gaining FDA clearance and the European CE mark, BrainsWay’s safe and effective Deep TMS therapy is at the forefront of mental health treatments that are offering patients a brighter future.
With more than 600 providers, BrainsWay can provide the care you need.
See all the latest news, events and in the media BrainsWay has to offer and everything in-between.
In the media September 15, 2020
Bre Hushaw walks Health.com through her in-depth account of how prior treatments for depression were...
In the media September 6, 2020
Observer interviews BrainsWay CEO, Dr. Christopher von Jako, discussing the growing mental health crisis...
News September 8, 2020
CRESSKILL, N.J. and JERUSALEM, Israel, September 8, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...
See all the latest mental health education articles and FAQs from BrainsWay.
Obsessive-compulsive disorder (OCD) is currently getting a great deal of attention, due in part to the...
Obsessive-compulsive disorder, or OCD, is an anxiety-based mental health condition that affects many...
Depression, or major depressive disorder (MDD) as it is defined by the American Psychiatric Association,...
